Use of an lfa-1 antagonist in the preparation of a medicament for the treatment of lfa-1 mediated disorders
Реферат: A method is provided for administering to a mammal suffering from, or at risk for, multiple sclerosis, an initial dosing of a therapeutically effective amount of an anti-LFA-1 antibody, followed by a subsequent intermittent dosing of a therapeutically effective amount of the anti-LFA-1 antibody wherein the antibody is administered to the mammal no more than once per week in the intermittent dosing.
Treatment of LFA-1 associated disorders with increasing doses
Номер патента: US20040047859A1. Автор: Karen Starko,Marvin Garovoy,Susan Kramer,Russell Dedrick. Владелец: Xoma Ltd. Дата публикации: 2004-03-11.